Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tema Heart & Health ETF (NQ:HRTS)

36.01 +0.26 (+0.73%)
Streaming Delayed Price Updated: 9:40 AM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 387
Open 36.01
Bid (Size) 35.95 (400)
Ask (Size) 36.04 (400)
Prev. Close 35.75
Today's Range 36.01 - 36.01
52wk Range 25.32 - 36.65
Shares Outstanding N/A
Dividend Yield 1.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing ↗
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp. 
Via Stocktwits
News headline image
Keros Therapeutics Stock Heads For Record Low After Dosing Halt In Pulmonary Disease Trial, Retail Buzz Spikes ↗
The company’s stock declined nearly 60% in 2024 and has lost an additional 21% in 2025, with this latest setback further dampening investor confidence. 
Via Stocktwits

Performance

YTD
+1.8%
+1.8%
1 Month
+0.7%
+0.7%
3 Month
+4.7%
+4.7%
6 Month
+23.1%
+23.1%
1 Year
+19.2%
+19.2%

More News

Read More
News headline image
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss ↗
Via Benzinga
News headline image
EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen' ↗
Via Benzinga
News headline image
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗
Via Benzinga
News headline image
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO ↗
Via Benzinga
Topics ETFs
News headline image
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients ↗
Via Investor's Business Daily
News headline image
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply ↗
Via Benzinga
News headline image
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test ↗
Via Investor's Business Daily
News headline image
Healthcare ETFs For The Weight-Loss Drug Boom And Beyond ↗
Via Talk Markets
Topics Artificial Intelligence ETFs
News headline image
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗
Via Investor's Business Daily
News headline image
Ozempic, Weygovy – Obesity And Heart Health Constitute A Major Market That Is Only Growing ↗
Via Benzinga
Topics ETFs
News headline image
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market ↗
Via Benzinga
News headline image
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads ↗
Via Benzinga
Topics ETFs

Frequently Asked Questions

Is Tema Heart & Health ETF publicly traded?
Yes, Tema Heart & Health ETF is publicly traded.
What exchange does Tema Heart & Health ETF trade on?
Tema Heart & Health ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Tema Heart & Health ETF?
The ticker symbol for Tema Heart & Health ETF is HRTS on the Nasdaq Stock Market
What is the current price of Tema Heart & Health ETF?
The current price of Tema Heart & Health ETF is 36.01
When was Tema Heart & Health ETF last traded?
The last trade of Tema Heart & Health ETF was at 02/17/26 09:40 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.